Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches-Reference-Cited by-同舟云学术

Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches

Published:2016-09 Issue:9 Volume:27 Page:1706-1712
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Udager A.M.,Liu T.-Y.,Skala S.L.,Magers M.J.,McDaniel A.S.,Spratt D.E.,Feng F.Y.,Siddiqui J.,Cao X.,Fields K.L.,Morgan T.M.,Palapattu G.S.,Weizer A.Z.,Chinnaiyan A.M.,Alva A.,Montgomery J.S.,Tomlins S.A.,Jiang H.,Mehra R.

Funder

Early Detection Research Network of the National Cancer Institute

A. Alfred Taubman Medical Research Institute

Howard Hughes Medical Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/9/1706/16698092/mdw216.pdf

Reference28 articles.

1. Incidence trends in primary malignant penile cancer;Barnholtz-Sloan;Urol Oncol,2007

2. EAU guidelines on penile cancer: 2014 update;Hakenberg;Eur Urol,2015

3. Immunotherapy: checkpoint parley;Bordon;Nat Rev Cancer,2015

4. Releasing the brakes on cancer immunotherapy;Littman;Cell,2015

5. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade;Iwai;Proc Natl Acad Sci USA,2002

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors;Current Cancer Drug Targets;2024-11

2. Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study;The Oncologist;2024-09-02

3. PTHrP-induced hypercalcemic psychosyndrome under combined anti-PD-L1 and anti-EGFR inhibition in penile squamous cell carcinoma – a case report;EJC Skin Cancer;2024-09

4. Immune-based Therapies for Penile Cancer;Urologic Clinics of North America;2024-08

5. New Therapeutic Horizons for Advanced or Metastatic Penile Cancer;Urologic Clinics of North America;2024-08